series-b
Stage
1
Investors
About
Starton Therapeutics is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, longer.
Explore Starton Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.